Jaguar Health (JAGX) Intangibles (2017 - 2026)
Jaguar Health (JAGX) reported Intangibles of $15.6 million for Q1 2026, down 13.65% year-over-year from $18.0 million in Q1 2025, and down 2.92% quarter-over-quarter from $16.0 million in Q4 2025.
Jaguar Health (JAGX) Intangibles (2017 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 10 years of Intangibles data on file, last reported at $15.6 million in Q1 2026.
- Intangibles for Q1 2026 came in at $15.6 million, down 13.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.6 million (down 13.65% YoY), and the FY2025 annual result was $16.0 million, down 13.3% from the prior year.
- Intangibles fell to $15.6 million in Q1 2026 per JAGX's latest filing, from $16.0 million in the prior quarter.
- Over five years, Intangibles peaked at $23.0 million in Q2 2022 and troughed at $12.5 million in Q3 2025.
- A 5-year average of $18.9 million and a median of $19.4 million in 2024 frame the typical range for Intangibles.
- On a YoY basis, Intangibles climbed as much as 16.47% in 2024 and fell as far as 32.55% in 2024.
- A 5-year view of Intangibles shows it stood at $22.4 million in 2022, then declined by 10.35% to $20.1 million in 2023, then fell by 8.14% to $18.5 million in 2024, then fell by 13.3% to $16.0 million in 2025, then slipped by 2.92% to $15.6 million in 2026.
- Business Quant data shows JAGX's Intangibles at $15.6 million in Q1 2026, $16.0 million in Q4 2025, and $12.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 7.73 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 15.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.55 Mn |
| Dec 31, 2025 | 16.02 Mn |
| Sep 30, 2025 | 12.49 Mn |
| Jun 30, 2025 | 17.55 Mn |
| Mar 31, 2025 | 18.01 Mn |
| Dec 31, 2024 | 18.48 Mn |
| Sep 30, 2024 | 14.15 Mn |
| Jun 30, 2024 | 19.41 Mn |
| Mar 31, 2024 | 19.63 Mn |
| Dec 31, 2023 | 20.12 Mn |
| Sep 30, 2023 | 20.97 Mn |
| Jun 30, 2023 | 16.66 Mn |
| Mar 31, 2023 | 21.95 Mn |
| Dec 31, 2022 | 22.44 Mn |
| Sep 30, 2022 | 22.56 Mn |
| Jun 30, 2022 | 22.99 Mn |
| Mar 31, 2022 | 22.23 Mn |
| Dec 31, 2021 | 22.65 Mn |
| Sep 30, 2021 | 23.07 Mn |
| Jun 30, 2021 | 23.49 Mn |